Dengue vaccine

From The Star,

Monday June 13, 2011

Liow: Dengue vaccine to be rolled out after final trial

BENTONG: The dengue vaccine developed by the Health Ministry and pharmaceutical company Sanofi-Aventis is expected to be rolled out once its clinical analysis is completed.

Minister Datuk Seri Liow Tiong Lai said the ministry was now awaiting the outcome of the final clinical trial on the vaccine.

“If it is successful, we will implement it nationwide.

“It has taken us four to five years and finally, the research for a vaccine to prevent dengue fever has borne fruit. It is a huge breakthrough as it will be the first in the world,” he said after opening the Bentong MCA annual general meeting yesterday.

It was reported that the latest phase of clinical trials, which began this month, target 1,500 subjects in Kuala Lumpur and Penang.

In Sungai Buloh, Selangor last night, Liow said Yayasan Selangor should stick to its core business of education including helping students in the state.

“Yayasan Selangor is not a property developer so there is no reason for the Selangor government to give them the plots of land,” said Liow, who is MCA deputy president.

Speaking to reporters at a Father and Mother’s Day celebration event held by MCA at Kampung Sri Indah A yesterday, Liow said the foundation should instead focus on ways to help students in the state.

There has been a controversy between the state and nursery operators following the state’s move to reject their TOL applications and award it to Yayasan Selangor.

One thought on “Dengue vaccine

  • December 13, 2011 at 3:43 am
    Permalink

    Dear Sir / Madam,
    I understand that clinical trials for dengue vaccine by Sanofi-Aventis has stopped recruitment due to lack of support from the regulatory wing of Ministry of Health.

    MOH should concentrate on supporting and popularizing early diagnostics by MyDENKit, a real time PCR based molecular diagnostic kit developed by Geneflux Biosciences.
    Early diagnostics of dengue virus and serotyping will reduce hospitalization cost to government. For more details and product presentation, contact Geneflux

Comments are closed.